Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

GreenLight Biosciences Holdings

GRNA

HealthcareNASDAQUS

$0.2995

-$0.0001 (-0.03%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

GRNA

1Y-0.0001 (-0.03%)

Candles, volume, SMA 20, and SMA 50

O 0.2995H 0.304L 0.2993C 0.2995Date Jul 21

GRNA

SMA 20 SMA 50 Vol 141.25KEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$45.43M

Volume?143.17K

Avg Volume?713.37K

52w Range$0.177 - $5.90

Beta?1.44

Price Performance

0.0%

$0.2995 to $0.2995

YTD

0.0%